Cargando…
Implementation of Medication Safety Practice in Childhood Acute Lymphoblastic Leukemia Treatment
OBJECTIVE: Medical Safety Practice (MSP) is a safe procedure in medication process. It is important to investigate the use of MSP among childhood cancer patients because pediatric oncology is a high-risk area for potentially harmful adverse events. The purpose of this study is to determine the effec...
Autores principales: | Mulatsih, Sri, Dwiprahasto, Iwan, Sutaryo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031849/ https://www.ncbi.nlm.nih.gov/pubmed/29801409 http://dx.doi.org/10.22034/APJCP.2018.19.5.1251 |
Ejemplares similares
-
Randomized double blind trial of ciprofloxacin prophylaxis during induction treatment in childhood acute lymphoblastic leukemia in the WK-ALL protocol in Indonesia
por: Widjajanto, Pudjo H, et al.
Publicado: (2013) -
Health-related quality of life assessment in Indonesian childhood acute lymphoblastic leukemia
por: Sitaresmi, Mei N, et al.
Publicado: (2008) -
Myeloid Antigen Expression in Childhood Acute Lymphoblastic Leukemia and Its Relevance for Clinical Outcome in Indonesian ALL-2006 Protocol
por: Supriyadi, Eddy, et al.
Publicado: (2012) -
The Microbiome in Childhood Acute Lymphoblastic Leukemia
por: Oldenburg, Marina, et al.
Publicado: (2021) -
Dyslipidemia at diagnosis of childhood acute lymphoblastic leukemia
por: Mogensen, Pernille Rudebeck, et al.
Publicado: (2020)